位置:首页 > 蛋白库 > NRG_DROME
NRG_DROME
ID   NRG_DROME               Reviewed;        1302 AA.
AC   P20241; A4V452; O61541; O61542; Q1WWD5; Q24414; Q24415; Q95U64; Q9V3X0;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 2.
DT   03-AUG-2022, entry version 221.
DE   RecName: Full=Neuroglian;
DE   Flags: Precursor;
GN   Name=Nrg; ORFNames=CG1634;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Endopterygota; Diptera; Brachycera; Muscomorpha; Ephydroidea;
OC   Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), AND PROTEIN SEQUENCE OF 24-41 AND
RP   737-751.
RX   PubMed=2805067; DOI=10.1016/0092-8674(89)90029-9;
RA   Bieber A.J., Snow P.M., Hortsch M., Patel N.H., Jacobs J.R., Traquina Z.R.,
RA   Schilling J., Goodman C.S.;
RT   "Drosophila neuroglian: a member of the immunoglobulin superfamily with
RT   extensive homology to the vertebrate neural adhesion molecule L1.";
RL   Cell 59:447-460(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING (ISOFORMS A AND
RP   B).
RX   PubMed=9666073; DOI=10.1016/s0378-1119(98)00273-x;
RA   Zhao G., Hortsch M.;
RT   "The analysis of genomic structures in the L1 family of cell adhesion
RT   molecules provides no evidence for exon shuffling events after the
RT   separation of arthropod and chordate lineages.";
RL   Gene 215:47-55(1998).
RN   [3]
RP   SEQUENCE REVISION.
RA   Hortsch M.;
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., Brandon R.C.,
RA   Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D., Wan K.H., Doyle C.,
RA   Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G., Abril J.F., Agbayani A.,
RA   An H.-J., Andrews-Pfannkoch C., Baldwin D., Ballew R.M., Basu A.,
RA   Baxendale J., Bayraktaroglu L., Beasley E.M., Beeson K.Y., Benos P.V.,
RA   Berman B.P., Bhandari D., Bolshakov S., Borkova D., Botchan M.R., Bouck J.,
RA   Brokstein P., Brottier P., Burtis K.C., Busam D.A., Butler H., Cadieu E.,
RA   Center A., Chandra I., Cherry J.M., Cawley S., Dahlke C., Davenport L.B.,
RA   Davies P., de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I.,
RA   Dietz S.M., Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C.,
RA   Dunn P., Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S.,
RA   Fleischmann W., Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M.,
RA   Glasser K., Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J., Hostin D.,
RA   Houston K.A., Howland T.J., Wei M.-H., Ibegwam C., Jalali M., Kalush F.,
RA   Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., Kimmel B.E., Kodira C.D.,
RA   Kraft C.L., Kravitz S., Kulp D., Lai Z., Lasko P., Lei Y., Levitsky A.A.,
RA   Li J.H., Li Z., Liang Y., Lin X., Liu X., Mattei B., McIntosh T.C.,
RA   McLeod M.P., McPherson D., Merkulov G., Milshina N.V., Mobarry C.,
RA   Morris J., Moshrefi A., Mount S.M., Moy M., Murphy B., Murphy L.,
RA   Muzny D.M., Nelson D.L., Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R.,
RA   Pacleb J.M., Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V.,
RA   Reese M.G., Reinert K., Remington K., Saunders R.D.C., Scheeler F.,
RA   Shen H., Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., Svirskas R.,
RA   Tector C., Turner R., Venter E., Wang A.H., Wang X., Wang Z.-Y.,
RA   Wassarman D.A., Weinstock G.M., Weissenbach J., Williams S.M., Woodage T.,
RA   Worley K.C., Wu D., Yang S., Yao Q.A., Ye J., Yeh R.-F., Zaveri J.S.,
RA   Zhan M., Zhang G., Zhao Q., Zheng L., Zheng X.H., Zhong F.N., Zhong W.,
RA   Zhou X., Zhu S.C., Zhu X., Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M.,
RA   Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [5]
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q., Stapleton M.,
RA   Yamada C., Ashburner M., Gelbart W.M., Rubin G.M., Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a systematic
RT   review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
RC   STRAIN=Berkeley; TISSUE=Head;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M., George R.A.,
RA   Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H., Rubin G.M.,
RA   Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1088-1302.
RC   STRAIN=Berkeley;
RA   Stapleton M., Carlson J.W., Chavez C., Frise E., George R.A., Pacleb J.M.,
RA   Park S., Wan K.H., Yu C., Celniker S.E.;
RL   Submitted (MAR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1182-1302 (ISOFORMS A AND B), FUNCTION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Embryo;
RX   PubMed=1693086; DOI=10.1016/0896-6273(90)90196-m;
RA   Hortsch M., Bieber A.J., Patel N.H., Goodman C.S.;
RT   "Differential splicing generates a nervous system-specific form of
RT   Drosophila neuroglian.";
RL   Neuron 4:697-709(1990).
RN   [9]
RP   IDENTIFICATION IN A COMPLEX WITH NRG AND CONT.
RX   PubMed=15459097; DOI=10.1242/dev.01372;
RA   Faivre-Sarrailh C., Banerjee S., Li J., Hortsch M., Laval M., Bhat M.A.;
RT   "Drosophila contactin, a homolog of vertebrate contactin, is required for
RT   septate junction organization and paracellular barrier function.";
RL   Development 131:4931-4942(2004).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-198 AND ASN-411, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Oregon-R; TISSUE=Head;
RX   PubMed=17893096; DOI=10.1093/glycob/cwm097;
RA   Koles K., Lim J.-M., Aoki K., Porterfield M., Tiemeyer M., Wells L.,
RA   Panin V.;
RT   "Identification of N-glycosylated proteins from the central nervous system
RT   of Drosophila melanogaster.";
RL   Glycobiology 17:1388-1403(2007).
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-411, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-linked
RT   cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 610-814, DISULFIDE BONDS, AND
RP   GLYCOSYLATION AT ASN-652 AND ASN-683.
RX   PubMed=7512815; DOI=10.1016/0896-6273(94)90326-3;
RA   Huber A.H., Wang Y.-M.E., Bieber A.J., Bjorkman P.J.;
RT   "Crystal structure of tandem type III fibronectin domains from Drosophila
RT   neuroglian at 2.0 A.";
RL   Neuron 12:717-731(1994).
CC   -!- FUNCTION: The long isoform may play a role in neural and glial cell
CC       adhesion in the developing embryo. The short isoform may be a more
CC       general cell adhesion molecule involved in other tissues and imaginal
CC       disk morphogenesis. Vital for embryonic development. Essential for
CC       septate junctions. Septate junctions, which are the equivalent of
CC       vertebrates tight junctions, are characterized by regular arrays of
CC       transverse structures that span the intermembrane space and form a
CC       physical barrier to diffusion. Required for the blood-brain barrier
CC       formation. {ECO:0000269|PubMed:1693086}.
CC   -!- SUBUNIT: Forms a complex with Nrx and Cont.
CC       {ECO:0000269|PubMed:15459097}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Cell junction, tight junction.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=B; Synonyms=180 kDa form;
CC         IsoId=P20241-1; Sequence=Displayed;
CC       Name=A; Synonyms=C, 167 kDa form;
CC         IsoId=P20241-2; Sequence=VSP_002601, VSP_002602;
CC   -!- TISSUE SPECIFICITY: Long isoform is restricted to surface of neurons
CC       and glia in the developing nervous system and the short isoform to
CC       other non-neuronal tissues. {ECO:0000269|PubMed:1693086}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M28231; AAA28728.2; -; mRNA.
DR   EMBL; AF050085; AAC28613.2; -; Genomic_DNA.
DR   EMBL; AF050084; AAC28613.2; JOINED; Genomic_DNA.
DR   EMBL; AF050085; AAC28614.2; -; Genomic_DNA.
DR   EMBL; AF050084; AAC28614.2; JOINED; Genomic_DNA.
DR   EMBL; AE014298; AAF46387.1; -; Genomic_DNA.
DR   EMBL; AE014298; AAN09236.1; -; Genomic_DNA.
DR   EMBL; AE014298; AAS65287.1; -; Genomic_DNA.
DR   EMBL; AY058284; AAL13513.1; -; mRNA.
DR   EMBL; BT024971; ABE01201.1; -; mRNA.
DR   EMBL; X76243; CAA53822.1; -; mRNA.
DR   EMBL; X76244; CAA53823.1; -; mRNA.
DR   PIR; A32579; A32579.
DR   RefSeq; NP_001162704.1; NM_001169233.2. [P20241-2]
DR   RefSeq; NP_001162705.1; NM_001169234.3. [P20241-1]
DR   RefSeq; NP_001162706.1; NM_001169235.1. [P20241-2]
DR   RefSeq; NP_001259336.1; NM_001272407.2. [P20241-2]
DR   RefSeq; NP_001259337.1; NM_001272408.1. [P20241-1]
DR   RefSeq; NP_511090.1; NM_078535.3. [P20241-2]
DR   RefSeq; NP_727274.1; NM_167160.2. [P20241-1]
DR   RefSeq; NP_996380.1; NM_206657.4. [P20241-2]
DR   PDB; 1CFB; X-ray; 2.00 A; A=610-814.
DR   PDBsum; 1CFB; -.
DR   AlphaFoldDB; P20241; -.
DR   SMR; P20241; -.
DR   BioGRID; 58251; 28.
DR   DIP; DIP-22412N; -.
DR   IntAct; P20241; 79.
DR   STRING; 7227.FBpp0297081; -.
DR   GlyGen; P20241; 8 sites.
DR   iPTMnet; P20241; -.
DR   PaxDb; P20241; -.
DR   DNASU; 31792; -.
DR   EnsemblMetazoa; FBtr0071207; FBpp0071154; FBgn0264975. [P20241-2]
DR   EnsemblMetazoa; FBtr0071208; FBpp0071155; FBgn0264975. [P20241-1]
DR   EnsemblMetazoa; FBtr0071209; FBpp0089326; FBgn0264975. [P20241-2]
DR   EnsemblMetazoa; FBtr0301762; FBpp0290976; FBgn0264975. [P20241-2]
DR   EnsemblMetazoa; FBtr0301763; FBpp0290977; FBgn0264975. [P20241-1]
DR   EnsemblMetazoa; FBtr0301764; FBpp0290978; FBgn0264975. [P20241-2]
DR   EnsemblMetazoa; FBtr0333522; FBpp0305702; FBgn0264975. [P20241-2]
DR   EnsemblMetazoa; FBtr0333523; FBpp0305703; FBgn0264975. [P20241-1]
DR   GeneID; 31792; -.
DR   KEGG; dme:Dmel_CG1634; -.
DR   UCSC; CG1634-RC; d. melanogaster.
DR   CTD; 31792; -.
DR   FlyBase; FBgn0264975; Nrg.
DR   VEuPathDB; VectorBase:FBgn0264975; -.
DR   eggNOG; KOG3513; Eukaryota.
DR   InParanoid; P20241; -.
DR   OMA; AGRGDYP; -.
DR   PhylomeDB; P20241; -.
DR   BioGRID-ORCS; 31792; 0 hits in 3 CRISPR screens.
DR   ChiTaRS; Nrg; fly.
DR   EvolutionaryTrace; P20241; -.
DR   GenomeRNAi; 31792; -.
DR   PRO; PR:P20241; -.
DR   Proteomes; UP000000803; Chromosome X.
DR   Bgee; FBgn0264975; Expressed in oviduct (Drosophila) and 44 other tissues.
DR   ExpressionAtlas; P20241; baseline and differential.
DR   Genevisible; P20241; DM.
DR   GO; GO:0030424; C:axon; IDA:FlyBase.
DR   GO; GO:0005923; C:bicellular tight junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0030425; C:dendrite; IDA:FlyBase.
DR   GO; GO:0030175; C:filopodium; IDA:FlyBase.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:FlyBase.
DR   GO; GO:0016020; C:membrane; IMP:FlyBase.
DR   GO; GO:0043025; C:neuronal cell body; IDA:FlyBase.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005919; C:pleated septate junction; IDA:FlyBase.
DR   GO; GO:0005918; C:septate junction; IDA:FlyBase.
DR   GO; GO:0005509; F:calcium ion binding; IDA:FlyBase.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IPI:FlyBase.
DR   GO; GO:0008366; P:axon ensheathment; IMP:FlyBase.
DR   GO; GO:0048675; P:axon extension; IMP:FlyBase.
DR   GO; GO:0007409; P:axonogenesis; IMP:FlyBase.
DR   GO; GO:0061343; P:cell adhesion involved in heart morphogenesis; IMP:FlyBase.
DR   GO; GO:0098609; P:cell-cell adhesion; IDA:FlyBase.
DR   GO; GO:0048036; P:central complex development; IMP:FlyBase.
DR   GO; GO:0048813; P:dendrite morphogenesis; IMP:FlyBase.
DR   GO; GO:0060857; P:establishment of glial blood-brain barrier; IMP:FlyBase.
DR   GO; GO:0008050; P:female courtship behavior; IMP:FlyBase.
DR   GO; GO:0007560; P:imaginal disc morphogenesis; IMP:UniProtKB.
DR   GO; GO:0008049; P:male courtship behavior; IMP:FlyBase.
DR   GO; GO:0035011; P:melanotic encapsulation of foreign target; IMP:FlyBase.
DR   GO; GO:0008045; P:motor neuron axon guidance; IMP:FlyBase.
DR   GO; GO:0016319; P:mushroom body development; IMP:FlyBase.
DR   GO; GO:0021682; P:nerve maturation; IMP:FlyBase.
DR   GO; GO:0007158; P:neuron cell-cell adhesion; IMP:UniProtKB.
DR   GO; GO:0072499; P:photoreceptor cell axon guidance; IMP:FlyBase.
DR   GO; GO:0045924; P:regulation of female receptivity; IMP:FlyBase.
DR   GO; GO:0035151; P:regulation of tube size, open tracheal system; IMP:FlyBase.
DR   GO; GO:0019991; P:septate junction assembly; IMP:FlyBase.
DR   GO; GO:0050808; P:synapse organization; IMP:FlyBase.
DR   CDD; cd00063; FN3; 5.
DR   Gene3D; 2.60.40.10; -; 11.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013151; Immunoglobulin.
DR   InterPro; IPR026966; Neurofascin/L1/NrCAM_C.
DR   Pfam; PF13882; Bravo_FIGEY; 1.
DR   Pfam; PF00041; fn3; 3.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF00047; ig; 2.
DR   SMART; SM00060; FN3; 5.
DR   SMART; SM00409; IG; 6.
DR   SMART; SM00408; IGc2; 6.
DR   SUPFAM; SSF48726; SSF48726; 6.
DR   SUPFAM; SSF49265; SSF49265; 3.
DR   PROSITE; PS50853; FN3; 5.
DR   PROSITE; PS50835; IG_LIKE; 6.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell junction;
KW   Cell membrane; Developmental protein; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Immunoglobulin domain; Membrane;
KW   Reference proteome; Repeat; Signal; Tight junction; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000269|PubMed:2805067"
FT   CHAIN           24..1302
FT                   /note="Neuroglian"
FT                   /id="PRO_0000015055"
FT   TOPO_DOM        24..1138
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1139..1154
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1155..1302
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          29..133
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          134..225
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          245..330
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          339..426
FT                   /note="Ig-like C2-type 4"
FT   DOMAIN          432..524
FT                   /note="Ig-like C2-type 5"
FT   DOMAIN          521..610
FT                   /note="Ig-like C2-type 6"
FT   DOMAIN          614..711
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          716..813
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          818..915
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          916..1017
FT                   /note="Fibronectin type-III 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1021..1119
FT                   /note="Fibronectin type-III 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   REGION          1172..1223
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1236..1291
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1190..1208
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        182
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        198
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:17893096"
FT   CARBOHYD        411
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:17893096,
FT                   ECO:0000269|PubMed:19349973"
FT   CARBOHYD        448
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        652
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:7512815"
FT   CARBOHYD        683
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:7512815"
FT   CARBOHYD        821
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1125
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        59..111
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        155..212
FT                   /evidence="ECO:0000250|UniProtKB:P25033"
FT   DISULFID        268..317
FT                   /evidence="ECO:0000250|UniProtKB:P25033"
FT   DISULFID        360..410
FT                   /evidence="ECO:0000250|UniProtKB:P25033"
FT   DISULFID        625..706
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:7512815"
FT   VAR_SEQ         1224..1239
FT                   /note="QFTEDGSFIGQYVPGK -> MNEDGSFIGQYGRKGL (in isoform A)"
FT                   /evidence="ECO:0000303|PubMed:12537569,
FT                   ECO:0000303|PubMed:1693086, ECO:0000303|PubMed:2805067"
FT                   /id="VSP_002601"
FT   VAR_SEQ         1240..1302
FT                   /note="Missing (in isoform A)"
FT                   /evidence="ECO:0000303|PubMed:12537569,
FT                   ECO:0000303|PubMed:1693086, ECO:0000303|PubMed:2805067"
FT                   /id="VSP_002602"
FT   CONFLICT        85..86
FT                   /note="NR -> KP (in Ref. 2; AAC28613/AAC28614)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1232
FT                   /note="Missing (in Ref. 7; ABE01201)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1282
FT                   /note="Missing (in Ref. 8; CAA53823)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1299
FT                   /note="A -> V (in Ref. 7; ABE01201)"
FT                   /evidence="ECO:0000305"
FT   STRAND          619..625
FT                   /evidence="ECO:0007829|PDB:1CFB"
FT   STRAND          627..635
FT                   /evidence="ECO:0007829|PDB:1CFB"
FT   STRAND          646..656
FT                   /evidence="ECO:0007829|PDB:1CFB"
FT   STRAND          661..668
FT                   /evidence="ECO:0007829|PDB:1CFB"
FT   STRAND          672..677
FT                   /evidence="ECO:0007829|PDB:1CFB"
FT   STRAND          680..692
FT                   /evidence="ECO:0007829|PDB:1CFB"
FT   STRAND          706..708
FT                   /evidence="ECO:0007829|PDB:1CFB"
FT   STRAND          721..723
FT                   /evidence="ECO:0007829|PDB:1CFB"
FT   STRAND          730..733
FT                   /evidence="ECO:0007829|PDB:1CFB"
FT   HELIX           739..741
FT                   /evidence="ECO:0007829|PDB:1CFB"
FT   STRAND          744..746
FT                   /evidence="ECO:0007829|PDB:1CFB"
FT   STRAND          748..757
FT                   /evidence="ECO:0007829|PDB:1CFB"
FT   STRAND          763..767
FT                   /evidence="ECO:0007829|PDB:1CFB"
FT   STRAND          774..777
FT                   /evidence="ECO:0007829|PDB:1CFB"
FT   STRAND          785..794
FT                   /evidence="ECO:0007829|PDB:1CFB"
FT   STRAND          806..812
FT                   /evidence="ECO:0007829|PDB:1CFB"
SQ   SEQUENCE   1302 AA;  143618 MW;  59BD9DF286756F1A CRC64;
     MWRQSTILAA LLVALLCAGS AESKGNRPPR ITKQPAPGEL LFKVAQQNKE SDNPFIIECE
     ADGQPEPEYS WIKNGKKFDW QAYDNRMLRQ PGRGTLVITI PKDEDRGHYQ CFASNEFGTA
     TSNSVYVRKA ELNAFKDEAA KTLEAVEGEP FMLKCAAPDG FPSPTVNWMI QESIDGSIKS
     INNSRMTLDP EGNLWFSNVT REDASSDFYY ACSATSVFRS EYKIGNKVLL DVKQMGVSAS
     QNKHPPVRQY VSRRQSLALR GKRMELFCIY GGTPLPQTVW SKDGQRIQWS DRITQGHYGK
     SLVIRQTNFD DAGTYTCDVS NGVGNAQSFS IILNVNSVPY FTKEPEIATA AEDEEVVFEC
     RAAGVPEPKI SWIHNGKPIE QSTPNPRRTV TDNTIRIINL VKGDTGNYGC NATNSLGYVY
     KDVYLNVQAE PPTISEAPAA VSTVDGRNVT IKCRVNGSPK PLVKWLRASN WLTGGRYNVQ
     ANGDLEIQDV TFSDAGKYTC YAQNKFGEIQ ADGSLVVKEH TRITQEPQNY EVAAGQSATF
     RCNEAHDDTL EIEIDWWKDG QSIDFEAQPR FVKTNDNSLT IAKTMELDSG EYTCVARTRL
     DEATARANLI VQDVPNAPKL TGITCQADKA EIHWEQQGDN RSPILHYTIQ FNTSFTPASW
     DAAYEKVPNT DSSFVVQMSP WANYTFRVIA FNKIGASPPS AHSDSCTTQP DVPFKNPDNV
     VGQGTEPNNL VISWTPMPEI EHNAPNFHYY VSWKRDIPAA AWENNNIFDW RQNNIVIADQ
     PTFVKYLIKV VAINDRGESN VAAEEVVGYS GEDRPLDAPT NFTMRQITSS TSGYMAWTPV
     SEESVRGHFK GYKIQTWTEN EGEEGLREIH VKGDTHNALV TQFKPDSKNY ARILAYNGRF
     NGPPSAVIDF DTPEGVPSPV QGLDAYPLGS SAFMLHWKKP LYPNGKLTGY KIYYEEVKES
     YVGERREYDP HITDPRVTRM KMAGLKPNSK YRISITATTK MGEGSEHYIE KTTLKDAVNV
     APATPSFSWE QLPSDNGLAK FRINWLPSTE GHPGTHFFTM HRIKGETQWI RENEEKNSDY
     QEVGGLDPET AYEFRVVSVD GHFNTESATQ EIDTNTVEGP IMVANETVAN AGWFIGMMLA
     LAFIIILFII ICIIRRNRGG KYDVHDRELA NGRRDYPEEG GFHEYSQPLD NKSAGRQSVS
     SANKPGVESD TDSMAEYGDG DTGQFTEDGS FIGQYVPGKL QPPVSPQPLN NSAAAHQAAP
     TAGGSGAAGS AAAAGASGGA SSAGGAAASN GGAAAGAVAT YV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024